foxo4-dri p53 Development of a novel senolytic by precise disruption of FOXO4-p53 complex FOXO4-DRI | Excenen PharmaTech
FOXO4 DRI Excenen PharmaTech Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data Peptide Inhibitors Targeting FOXO4 p53 Interactions and Inducing Senescent Cancer Cell specific Apoptosis Journal of Medicinal Chemistry Molecular models of the FOXO4:p53 DBD and FOXO4 DRI: p53 DBD complexes. Download Scientific Diagram
Pay in 4 interest-free payments of $5.88 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4




